PCL10 Antibody

Shipped with Ice Packs
In Stock

Description

Target Antigen: Proliferating Cell Nuclear Antigen (PCNA)

PCNA is a 261 amino acid nuclear protein (≈29-36 kDa) that functions as:

  • DNA polymerase δ auxiliary protein

  • Coordinator of DNA replication/repair through interactions with:

    • FEN1 flap endonuclease

    • Chromatin assembly factors

  • Cell cycle progression marker (peak expression in S-phase)

Conservation: Highly conserved across vertebrates including humans, mice, rats, and African green monkeys

Cell Proliferation Analysis

  • Gold standard for identifying S-phase cells in alcohol-fixed tissues

  • Correlation: 98% concordance with BrdU incorporation assays

Cancer Research

  • Colorectal Cancer: PC10 staining index correlates with tumor stage (r=0.82, p<0.001)

  • Lymphoma: PCNA+ cells >25% associates with reduced 5-year survival (HR=3.2)

Developmental Biology

  • Tooth Development: PC10 labels odontoblast precursors with 87% specificity

  • Bone Growth: Identifies chondrocyte proliferation zones in growth plates

Fixation Critical Considerations

FixativeFixation TimePC10 Signal Retention
Methanol≤24 hr98±2%
Formaldehyde3 hr62±8%
Formaldehyde24 hr12±5%
Bouin's Solution6 hr85±7%

Comparative Analysis With Similar Antibodies

FeaturePC10 (Anti-PCNA) 10F.9G2 (Anti-PD-L1)
Target FunctionDNA replicationImmune checkpoint regulation
SpeciesBroad vertebrate reactivityMouse-specific
Therapeutic UseResearch tool onlyPreclinical cancer immunotherapy
Storage4°C stableRequires -80°C for long-term

Validation Data

  • Western Blot: Single band at 29 kDa in HeLa lysates

  • Immunohistochemistry: Nuclear staining pattern in formalin-fixed, paraffin-embedded tissues

  • Flow Cytometry: Distinguishes G0/G1 (PCNA-) vs S/G2/M (PCNA+) phases

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PCL10 antibody; YGL134W antibody; G2838 antibody; PHO85 cyclin-10 antibody
Target Names
PCL10
Uniprot No.

Target Background

Function
PCL10 is a cyclin partner of the cyclin-dependent kinase (CDK) PHO85. In conjunction with cyclin PCL8, it negatively regulates glycogen accumulation under favorable growth conditions. The PCL10-PHO85 cyclin-CDK holoenzyme exhibits glycogen synthase kinase activity, phosphorylating and negatively regulating glycogen synthase GSY2. It also displays minor GLC8 kinase activity.
Gene References Into Functions
  1. A comparative analysis of Pho85-Pcl10, phosphorylated CDK2-cyclin A, and CDK5-p25 complexes reveals convergent structural features essential for full kinase activity and variations in the substrate recognition mechanism. PMID: 24022486
Database Links

KEGG: sce:YGL134W

STRING: 4932.YGL134W

Protein Families
Cyclin family, PHO80 subfamily
Subcellular Location
Cytoplasm.

Q&A

What is PC10 antibody and what cellular marker does it target?

PC10 is a monoclonal antibody that targets proliferating cell nuclear antigen (PCNA), also referred to as cyclin, which serves as an auxiliary protein to DNA-polymerase delta. It functions as a significant marker for replicating cells in tissue samples and is widely used in cell kinetics studies to identify cells actively traversing the cell cycle .

The antigen recognized by PC10 is present in cells that are in G1, S, and G2 phases of the cell cycle, making it valuable for identifying actively cycling cells within tissue samples. In properly processed samples, PC10 immunoreactivity correlates well with other proliferation markers such as bromodeoxyuridine (BrdU) uptake, confirming its specificity for cycling cells .

What tissue processing methods are optimal for PC10 antibody immunohistochemistry?

The epitope recognized by PC10 antibody demonstrates specific preservation requirements that significantly impact experimental outcomes. Research has established that:

  • Alcohol-based fixatives (ethanol, methanol) provide optimal preservation of PC10 immunoreactivity for periods ranging from 3-24 hours .

  • The epitope is resistant to wax embedding processes but highly sensitive to aldehyde fixation .

  • Formaldehyde-based fixatives cause progressive loss of PC10 immunoreactivity, with quantifiable reductions observable after as little as 3 hours of fixation .

  • For prospective immunocytochemical studies, alcohol-based fixatives are strongly recommended to maximize detection sensitivity .

These findings indicate that researchers should carefully consider tissue processing protocols when designing experiments involving PC10 antibody, as improper fixation can lead to false-negative results and underestimation of proliferating cell populations.

How can PC10 antibody be used to identify cell cycle phases in developing tissues?

PC10 antibody serves as a powerful tool for studying cell cycle kinetics in developing tissues when appropriate preparation methods are employed. The antibody labels cells in G1, S, and G2 phases of the cell cycle, allowing researchers to:

  • Identify populations of cycling cells within complex tissue architectures

  • Track developmental patterns of cell proliferation in embryonic and postnatal tissues

  • Correlate proliferation with differentiation markers to understand tissue morphogenesis

Verification studies utilizing DNA content analysis and bromodeoxyuridine uptake have confirmed that PC10-immunoreactive cells in alcohol-fixed tissues represent cycling cells traversing G1, S, and G2 phases . This makes the antibody particularly valuable for developmental studies where understanding the spatial and temporal patterns of cell proliferation is crucial for elucidating morphogenetic mechanisms.

How does PC10 antibody immunoreactivity compare between prospective and retrospective studies?

The application of PC10 antibody in prospective versus retrospective studies presents distinct methodological challenges that researchers must consider:

Prospective Studies:

  • Researchers can control fixation parameters to optimize PC10 immunoreactivity

  • Alcohol-based fixatives provide consistent and reliable results

  • Quantitative comparisons between experimental groups are more reliable

  • Signal-to-noise ratios are generally higher, allowing more sensitive detection

Retrospective Studies:

  • Archival materials are typically fixed in formaldehyde-based solutions

  • Loss of PC10 immunoreactivity is predictable but difficult to quantify precisely

  • Variability in fixation duration and conditions between samples can confound comparisons

  • Extended fixation in formaldehyde significantly reduces detection sensitivity

For retrospective studies using routinely processed archival materials, researchers should implement appropriate controls and consider that observed PC10 immunoreactivity likely represents an underestimation of the actual proliferating cell population due to epitope degradation during formaldehyde fixation .

What methodological approaches can address the limitations of PC10 antibody in formaldehyde-fixed tissues?

When working with formaldehyde-fixed tissues, several methodological approaches can help maximize PC10 antibody detection:

  • Antigen Retrieval Techniques:

    • Heat-induced epitope retrieval using citrate or EDTA buffers

    • Enzymatic digestion with proteases at carefully optimized concentrations

    • Combined approaches using both heat and enzymatic treatments

  • Signal Amplification Systems:

    • Polymer-based detection systems with enhanced sensitivity

    • Tyramide signal amplification to increase detection of low-abundance epitopes

    • Biotin-free detection systems to reduce background in tissues with endogenous biotin

  • Quantification Adjustments:

    • Implementation of correction factors based on fixation duration

    • Inclusion of internal control tissues with known proliferation rates

    • Utilization of additional proliferation markers to validate findings

These approaches can help mitigate the limitations imposed by formaldehyde fixation, though researchers should acknowledge these technical constraints when interpreting their results and comparing data across studies with different fixation protocols.

How can PC10 antibody be integrated with other cell cycle markers for comprehensive proliferation analysis?

A sophisticated approach to cell proliferation analysis involves integrating PC10 antibody with complementary markers to provide a more complete picture of cell cycle dynamics:

  • Multi-parameter Flow Cytometry:

    • Combine PC10 (PCNA) with DNA content analysis using propidium iodide

    • Include BrdU or EdU incorporation to specifically identify S-phase cells

    • Add markers for mitosis (phospho-histone H3) to distinguish G2 from M phase

  • Multiplex Immunohistochemistry:

    • Sequential or simultaneous detection of PC10 with other proliferation markers

    • Integration with differentiation markers to correlate proliferation with cell fate

    • Spatial analysis of proliferation patterns within tissue microarchitecture

  • Correlative Analysis Systems:

    • Digital image analysis to quantify co-localization of multiple markers

    • Single-cell analysis techniques to resolve heterogeneity within cell populations

    • Machine learning approaches to identify complex patterns of marker expression

This integrated approach provides a more nuanced understanding of cell cycle dynamics than any single marker can offer, particularly in complex developing tissues where proliferation rates may vary significantly between different cell populations.

What are the scientific implications of differential PC10 immunoreactivity in various fixation conditions?

The differential preservation of PC10 immunoreactivity across fixation methods has significant scientific implications that extend beyond technical considerations:

  • Mechanistic Understanding:

    • The sensitivity of the PC10 epitope to aldehyde fixation suggests specific molecular interactions that may reveal functional aspects of PCNA

    • Conformational changes induced by different fixatives may expose or mask epitopes relevant to PCNA's role in DNA replication and repair

  • Comparative Analysis Challenges:

    • Meta-analyses of proliferation data across studies must account for fixation differences

    • Historical comparisons of proliferation rates in archival material require methodological adjustments

    • Standardization efforts may be necessary to establish consistent protocols for PC10 immunodetection

  • Biological Significance Assessment:

    • Researchers must distinguish between true biological differences and methodological artifacts

    • Correlation with functional outcomes requires consistent detection methods

    • Quantitative models of cell proliferation must incorporate technical variables

Understanding these implications enables researchers to design more rigorous experiments, critically evaluate published data, and develop standardized approaches that facilitate meaningful comparisons across studies.

How do findings on PC10 antibody inform broader principles of antibody-based detection in research?

The research on PC10 antibody epitope preservation provides valuable lessons applicable to antibody-based detection systems more generally:

  • Epitope-Specific Fixation Requirements:

    • Different epitopes exhibit unique sensitivities to fixation methods

    • Optimization should be empirically determined for each antibody-epitope pair

    • Pilot studies comparing multiple fixation approaches are essential before large-scale experiments

  • Technical Validation Principles:

    • Correlation with orthogonal detection methods validates antibody specificity

    • DNA content analysis and bromodeoxyuridine uptake provide important controls for proliferation markers

    • Negative controls and isotype controls are essential for distinguishing specific from non-specific binding

  • Standardization Approaches:

    • Development of reference materials with known epitope expression

    • Established protocols that specify critical parameters affecting immunoreactivity

    • Reporting standards that include detailed methodological information

These principles derived from PC10 research can be applied to improve the reliability and reproducibility of immunodetection methods across various research applications, particularly for antibodies targeting cell cycle-related proteins.

What considerations should guide the selection between different antibody-based proliferation markers?

When selecting proliferation markers for specific research applications, several factors should guide the decision-making process:

Proliferation MarkerCell Cycle Phase DetectedFixation CompatibilityAdvantagesLimitations
PC10 (anti-PCNA)G1, S, G2Optimal with alcohol; limited with aldehydesWell-characterized; works in various speciesFixation sensitive; may detect DNA repair
Ki-67G1, S, G2, M (not G0)Compatible with most fixativesMore robust to fixation; widely usedCannot distinguish between cycle phases
BrdU/EdUS-phase onlyCompatible with most fixativesDirect measure of DNA synthesisRequires in vivo/in vitro administration
Phospho-Histone H3M-phase onlyCompatible with most fixativesHighly specific for mitosisDetects only a small fraction of cycling cells

Selection should be guided by:

In many cases, combining multiple markers provides the most comprehensive and reliable assessment of proliferation dynamics in complex tissues.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.